Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;31(5):486-95.
doi: 10.1007/s00774-013-0476-3. Epub 2013 Jun 6.

IL-34 and CSF-1: similarities and differences

Affiliations
Review

IL-34 and CSF-1: similarities and differences

Yuko Nakamichi et al. J Bone Miner Metab. 2013 Sep.

Abstract

Colony-stimulating factor-1 (CSF-1) is widely expressed and considered to regulate the development, maintenance, and function of mononuclear phagocyte lineage cells such as monocytes, macrophages, dendritic cells (DCs), Langerhans cells (LCs), microglia, and osteoclasts. Interleukin-34 (IL-34) was recently identified as an alternative ligand for the CSF-1 receptor (CSF-1R) through functional proteomics experiments. It is well established that the phenotype of CSF-1R-deficient (CSF-1R⁻/⁻) mice is more severe than that of mice bearing a spontaneous null mutation in CSF-1 (CSF-1(op/op)). CSF-1R⁻/⁻ mice are severely depleted of macrophages and completely lack LCs, microglia, and osteoclasts during their lifetime. In contrast, CSF-1(op/op) mice exhibit late-onset macrophage development and osteoclastogenesis, whereas they show modestly reduced numbers of microglia and a relatively normal LC development. In contrast, IL-34-deficient (IL-34⁻/⁻) mice show a marked reduction of LCs and a decrease in microglia. IL-34 and CSF-1 display different spatiotemporal expression patterns and have distinct biological functions. In this review, we focus on the functional similarities and differences between IL-34 and CSF-1 in vivo.

PubMed Disclaimer

References

    1. Gynecol Oncol. 2001 Feb;80(2):194-200 - PubMed
    1. Blood. 2012 Feb 23;119(8):1810-20 - PubMed
    1. J Exp Med. 2012 Jun 4;209(6):1167-81 - PubMed
    1. Clin Cancer Res. 1995 Mar;1(3):313-25 - PubMed
    1. J Leukoc Biol. 2010 May;87(5):753-64 - PubMed

Substances

LinkOut - more resources